Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Center, Randomized, Double-Blind, Two-Formulation, Single-Dose, Two-Period Crossover Clinical Trial Comparing Pharmacokinetics and Pharmacodynamics of Human Insulin Injection

NCT07608692 is registered in ClinicalTrials.gov with Zhuhai United Laboratories Co., Ltd. as lead sponsor.

NCT NCT07608692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07608692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Center, Randomized, Double-Blind, Two-Formulation, Single-Dose, Two-Period Crossover Clinical Trial Comparing Pharmacokinetics and Pharmacodynamics of Human Insulin Injection
Lead sponsor
Zhuhai United Laboratories Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
August 4, 2025
Completion date
January 13, 2026
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacokinetics and pharmacodynamics